Connor, Clark & Lunn Investment Management Ltd. Corcept Therapeutics Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 796,795 shares of CORT stock, worth $50.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

796,795

Previous 859,563 7.3%

Holding current value

$50.6 Million

Previous $39.8 Million 0.97%

% of portfolio

0.2%

Previous 0.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$44.66 - $60.85 $2.8 Million - $3.82 Million	-62,768 Reduced 7.3%	796,795 $40.2 Million
Q3 2024 Nov 08, 2024	BUY	$29.51 - $46.26 $4.23 Million - $6.64 Million	143,507 Added 20.04%	859,563 $39.8 Million
Q2 2024 Aug 09, 2024	BUY	$22.21 - $34.48 $3.86 Million - $6 Million	173,878 Added 32.07%	716,056 $23.3 Million
Q1 2024 May 09, 2024	BUY	$21.1 - $27.46 $3.82 Million - $4.97 Million	180,971 Added 50.1%	542,178 $13.7 Million
Q4 2023 Feb 09, 2024	SELL	$24.82 - $32.88 $30,503 - $40,409	-1,229 Reduced 0.34%	361,207 $11.7 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $10,369 - $15,953	-472 Reduced 0.13%	362,436 $9.88 Million
Q2 2023 Aug 10, 2023	BUY	$21.44 - $25.15 $3.04 Million - $3.57 Million	141,896 Added 64.2%	362,908 $8.07 Million
Q1 2023 May 09, 2023	BUY	$19.2 - $24.47 $1.58 Million - $2.01 Million	82,269 Added 59.3%	221,012 $4.79 Million
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $1.13 Million - $1.69 Million	56,445 Added 68.59%	138,743 $2.82 Million
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $188,559 - $222,302	7,634 Added 10.22%	82,298 $2.11 Million
Q2 2022 Aug 05, 2022	SELL	$17.33 - $25.3 $1.09 Million - $1.59 Million	-62,886 Reduced 45.72%	74,664 $1.78 Million
Q1 2022 May 12, 2022	BUY	$16.53 - $25.21 $1.48 Million - $2.26 Million	89,449 Added 185.96%	137,550 $3.1 Million
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $619,892 - $846,098	36,251 Added 305.92%	48,101 $952,000
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $233,208 - $266,980	11,850 New	11,850 $233,000

Others Institutions Holding CORT

# of Institutions

403

Shares Held

84.3M

Call Options Held

1.04M

Put Options Held

1.33M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Corcept Therapeutics Inc Transaction History